MedTrace Logo

Exspanding the Knowledge About TNPO2-Associated Disorders

NCT07699510 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-07-13

No results posted yet for this study

Summary

The Target-TNPO2 is an international, multicenter observational registry designed to collect comprehensive clinical, genetic, neurodevelopmental, and longitudinal data from individuals with pathogenic or likely pathogenic variants in the TNPO2 gene.

This aids to improve the knowledge and clinical progression on TNPO2-associated disorders.

The investigators further aim to provide new insides into the pathomechanism of TNPO2 variants using blood samples.

Conditions

  • TNPO2

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2036-06-30
Completion
2036-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07699510 on ClinicalTrials.gov